BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 12955681)

  • 1. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.
    Uribarri J; Peppa M; Cai W; Goldberg T; Lu M; Baliga S; Vassalotti JA; Vlassara H
    Am J Kidney Dis; 2003 Sep; 42(3):532-8. PubMed ID: 12955681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients.
    Uribarri J; Peppa M; Cai W; Goldberg T; Lu M; He C; Vlassara H
    J Am Soc Nephrol; 2003 Mar; 14(3):728-31. PubMed ID: 12595509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.
    Uribarri J; Cai W; Peppa M; Goodman S; Ferrucci L; Striker G; Vlassara H
    J Gerontol A Biol Sci Med Sci; 2007 Apr; 62(4):427-33. PubMed ID: 17452738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study.
    Martens RJH; Broers NJH; Canaud B; Christiaans MHL; Cornelis T; Gauly A; Hermans MMH; Konings CJAM; van der Sande FM; Scheijen JLJM; Stifft F; Wirtz JJJM; Kooman JP; Schalkwijk CG
    PLoS One; 2019; 14(8):e0221058. PubMed ID: 31408493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
    Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
    J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
    Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
    Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia.
    Degenhardt TP; Grass L; Reddy S; Thorpe SR; Diamandis EP; Baynes JW
    Kidney Int; 1997 Oct; 52(4):1064-7. PubMed ID: 9328946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study.
    Semba RD; Ang A; Talegawkar S; Crasto C; Dalal M; Jardack P; Traber MG; Ferrucci L; Arab L
    Eur J Clin Nutr; 2012 Jan; 66(1):3-9. PubMed ID: 21792213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial.
    Yacoub R; Nugent M; Cai W; Nadkarni GN; Chaves LD; Abyad S; Honan AM; Thomas SA; Zheng W; Valiyaparambil SA; Bryniarski MA; Sun Y; Buck M; Genco RJ; Quigg RJ; He JC; Uribarri J
    PLoS One; 2017; 12(9):e0184789. PubMed ID: 28931089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.
    Lapolla A; Reitano R; Seraglia R; Sartore G; Ragazzi E; Traldi P
    Mol Nutr Food Res; 2005 Jul; 49(7):685-90. PubMed ID: 15926142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.
    Koschinsky T; He CJ; Mitsuhashi T; Bucala R; Liu C; Buenting C; Heitmann K; Vlassara H
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6474-9. PubMed ID: 9177242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible significance of advanced glycation end products in serum in end-stage renal disease and in late complications of diabetes.
    Dolhofer-Bliesener R; Lechner B; Gerbitz KD
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):355-61. PubMed ID: 8704053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients.
    Takeuchi M; Makita Z; Yanagisawa K; Kameda Y; Koike T
    Mol Med; 1999 Jun; 5(6):393-405. PubMed ID: 10415164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis techniques and advanced glycation end products.
    Tessitore N; Lapolla A; Aricó CN; Gammaro L; Bernich P; Fedele D
    Contrib Nephrol; 2001; (131):33-9. PubMed ID: 11125561
    [No Abstract]   [Full Text] [Related]  

  • 15. Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat.
    Davis KE; Prasad C; Vijayagopal P; Juma S; Adams-Huet B; Imrhan V
    Br J Nutr; 2015 Dec; 114(11):1797-806. PubMed ID: 26392152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
    van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
    Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
    Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
    Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The advanced glycation endproduct pentosidine and monocyte activation in uremia.
    Friedlander MA; Witko-Sarsat V; Nguyen AT; Wu YC; Labrunte M; Verger C; Jungers P; Descamps-Latscha B
    Clin Nephrol; 1996 Jun; 45(6):379-82. PubMed ID: 8793229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio.
    Kalousová M; Sulková S; Zima T; Deppisch R; Beck W; Bednárová sV; Fortová M; Tesar V
    Ren Fail; 2003 Mar; 25(2):277-86. PubMed ID: 12739834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men.
    Macías-Cervantes MH; Rodríguez-Soto JM; Uribarri J; Díaz-Cisneros FJ; Cai W; Garay-Sevilla ME
    Nutrition; 2015 Mar; 31(3):446-51. PubMed ID: 25701333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.